Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Глобальная статистика рака за 2022 год: оценки GLOBOCAN заболеваемости и смертности от 36 видов рака в 185 странах мира
2024-04-04
SCID: 54.1/6hs7fxks
Discuss with AI
GLOBOCAN 2022cancer incidence and mortalitycancer prevention and controlglobal cancer statisticsworldwide cancer burden
Figures from the paper
Abstract (AI)
This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four-fold to five-fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South-Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics-based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades.
Key Findings
1
Approximately one in five men or women develop cancer during their lifetime; cancer causes death in about one in nine men and one in 12 women.
2
Cancer incidence varied four- to five-fold across world regions, and demographic projections indicate approximately 35 million new cases annually by 2050, emphasizing prevention targeting smoking, obesity, and infections.
3
Lung cancer was the most commonly diagnosed cancer globally, with nearly 2.5 million cases, and the leading cause of cancer death, causing approximately 1.8 million deaths.
4
The 2022 global cancer burden approached 20 million new cases and 9.7 million deaths, including nonmelanoma skin cancers.
5
The five leading cancers by incidence were lung, female breast, colorectal, prostate, and stomach cancers; the leading causes of death were lung, colorectal, liver, female breast, and stomach cancers.
Research Object
Global cancer incidence and mortality in 2022 across 36 cancers in 185 countries (GLOBOCAN estimates)
Research Subject
Geographic variation, leading cancer types, recent trends, determinants, and prospects for global cancer prevention and control
Publication Details
Publication Date
2024-04-04
Journal
Publisher
ISSN
Cited by
29388
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai9
Global cancer statistics2011
Global cancer statistics, 20122015
Global Cancer Statistics, 20022005
Cancer statistics, 20232023
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer2015
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial2002
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods2018
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial2020
International Agency for Research on Cancer (IARC)2018
Cited by17
Breast cancer: pathogenesis and treatments2025
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy2024
Hepatocellular carcinoma: signaling pathways and therapeutic advances2025
Emerging role of exosomes in cancer therapy: progress and challenges2025
Advances in smart nanotechnology-supported photodynamic therapy for cancer2024
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine2025
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer2025
External Test of a Deep Learning Algorithm for Pulmonary Nodule Malignancy Risk Stratification Using European Screening Data2025
MRI-based radiomics for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis2025
Emerging strategies in radiation therapy: promises and challenges of spatial fractionation, ultra-high dose rates, and nanoparticles2025
LAT1-specific PET radiotracers: Development and clinical experiences of a new class of cancer-specific radiopharmaceuticals2025
Effects of mindfulness-based interventions on cognitive impairment in patients with cancer: A systematic review and meta-analysis2025
Psychometric Properties of the Depression Anxiety Stress Scales (DASS-42 and DASS-21) in Patients with Hematologic Malignancies2025
Advances in risk prediction models for cancer-related cognitive impairment2025
A latent profile analysis of financial toxicity and its association with anxiety and depression in patients with hematologic malignancies2025
Encapsulation of a Cyclometalated Iridium(III) Photosensitizer into Nanosized Micelles for Oncosis-Inducing Photodynamic Therapy2026
Targeting the DNA methylation–H3K27me3 switch reverses castration resistance and immunosuppression via ADAMTS1-driven collagenolysis2026